AIHCC
Index Performance
+6.45%
AIHCC
+9.78%
IBB
Overview
Description
The Intelligent Healthcare Conviction strategy (AIHC) uses OpenAI's ChatGPT, Google's Bard, and Inflection AI's Claude to build an equal weighted portfolio of the committee's highest conviction US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHCC
- Inception Date10/16/2023
- WeightingEqual
- # of holdings33
What's inside?
Holdings
All holdings as of September 18, 2024
CSV download
| Align Technology, Inc. (ALGN) | 3.74% | $18.90B | 2.63% | 70.80% | 4.44 |
| IDEXX Laboratories, Inc. (IDXX) | 3.65% | $42.08B | 6.35% | 61.87% | 10.91 |
| Fresenius Medical Care AG (FME) | 3.64% | $12.22B | -1.22% | 24.47% | 1.15 |
| CONMED Corp. (CNMD) | 3.58% | $2.34B | 4.42% | 52.35% | 2.43 |
| Gilead Sciences, Inc. (GILD) | 3.52% | $104.44B | 5.46% | 77.78% | 3.78 |
| CVS Health Corp. (CVS) | 3.41% | $73.49B | 2.59% | 14.75% | 0.39 |
| Amgen, Inc. (AMGN) | 3.40% | $178.89B | 19.90% | 61.17% | 7.24 |
| Bayer AG (BAYN) | 3.39% | $30.53B | 0.91% | 55.19% | 1.46 |
| Olympus Corp. (7733) | 3.38% | $21.16B | 13.05% | 66.52% | 3.11 |
| Viatris, Inc. (VTRS) | 3.35% | $14.20B | -3.18% | 38.21% | 1.91 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.34% | $122.38B | 6.02% | 85.88% | 11.25 |
| Laboratory Corp. of America Holdings (LH) | 3.32% | $19.04B | 6.17% | 26.83% | 1.83 |
| Terumo Corp. (4543) | 3.32% | $27.54B | 19.95% | 53.28% | 4.08 |
| Quest Diagnostics, Inc. (DGX) | 3.32% | $17.31B | 2.52% | 32.37% | 2.17 |
| Edwards Lifesciences Corp. (EW) | 3.29% | $40.68B | -9.43% | 78.51% | 9.10 |
| GSK Plc (GSK) | 3.27% | $86.41B | 9.84% | 73.60% | 2.43 |
| AbbVie, Inc. (ABBV) | 3.27% | $340.80B | 4.31% | 71.01% | 6.57 |
| Chugai Pharmaceutical Co., Ltd. (4519) | 3.27% | $78.31B | 18.13% | 72.16% | 7.93 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 3.26% | $123.47B | 12.32% | 83.06% | 8.46 |
| ResMed, Inc. (RMD) | 3.25% | $34.97B | 10.95% | 55.68% | 6.16 |
| Cardinal Health, Inc. (CAH) | 3.25% | $26.96B | 10.65% | 3.15% | 0.11 |
| UnitedHealth Group, Inc. (UNH) | 3.25% | $536.18B | 6.41% | N/A | 1.45 |
| CSL Ltd. (CSL) | 3.25% | $96.95B | 14.46% | 48.68% | 7.23 |
| Cochlear Ltd. (COH) | 3.24% | $12.83B | 15.47% | 75.11% | 9.55 |
| Biogen, Inc. (BIIB) | 3.23% | $28.78B | 0.09% | 70.05% | 4.17 |
| Novo Nordisk A/S (NOVO.B) | 3.21% | $442.07B | 25.34% | 84.90% | 17.38 |
| Moderna, Inc. (MRNA) | 3.21% | $26.85B | -29.94% | 35.27% | 7.61 |
| Roche Holding AG (RO) | 3.20% | $256.85B | -7.21% | 73.06% | 3.99 |
| Eli Lilly & Co. (LLY) | 3.17% | $860.11B | 35.98% | 80.80% | 21.69 |
| McKesson Corp. (MCK) | 2.98% | $66.35B | 6.44% | 3.73% | 0.26 |
| Johnson & Johnson (JNJ) | 0.03% | $399.96B | -12.12% | 68.99% | 4.27 |
| Zoetis, Inc. (ZTS) | 0.01% | $89.02B | 8.30% | 70.22% | 9.45 |
| Universal Health Services, Inc. (UHS) | <0.01% | $13.96B | 10.13% | 11.17% | 1.17 |
Market data by FactSet